分子標的療法は外科治療をどう変えるか  7.大腸癌

文献

J-GLOBAL ID：201702249483478735 整理番号：17A1541860

HOW WILL MOLECULAR-TARGETED THERAPIES AFFECT SURGICAL TREATMENT?

出版者サイト {{ this.onShowPLink() }} 複写サービスで全文入手 {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=17A1541860&COPY=1") }}
高度な検索・分析はJDreamⅢで {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1541860&from=J-GLOBAL&jstjournalNo=Z0009B") }}

著者 (4件)： , , ,
資料名：
巻： 118 号： 6 ページ： 639-645 発行年： 2017年11月01日
JST資料番号： Z0009B ISSN： 0301-4894 資料種別：逐次刊行物 (A)
記事区分：解説発行国：日本 (JPN) 言語：日本語 (JA)

新規抗癌剤や分子標的治療薬の登場に伴い,近年の切除不能進行再...

,...
,...

続きはJDreamIII（有料）にて {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1541860&from=J-GLOBAL&jstjournalNo=Z0009B") }}

消化器の腫よう

引用文献 (20件)：

Stintzing S, Modest DP, Rossius L, et al.: FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3) : a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial. Lancet Oncol, 17 : 1426-1434, 2016.
Venock AP, Niedzwiecki D, Lenz HJ, et al.: CALGB/SWOG 80405 : Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC). J Clin Oncol, 32 : 5s(suppl; abstr LBA3), 2014.
Saltz LB, Clarke S, Díaz-Rubio E, et al. : Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer : a randomized phase III study. J Clin Oncol, 26 : 2013-2019, 2008.
Van Cutsem E, Köhne CH, Hitre E, et al.: Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med, 360 :1408-1417, 2009.
Douillard JY, Siena S, Cassidy J, et al. : Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer : the PRIME study. J Clin Oncol, 28 : 4697-4705, 2010.

, ,

前のページに戻る